Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2019-03-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The French government has put in place three national palliative care development programs: 2002-2005, 2008-2012, 2015-2018. The last program has unlocked a budget of 190 million euros for their development. It has been estimated from Social Security reimbursements, that the costs per patient over their last years of life are 26,000 euros, for a total of 13.5 million euros.
One of the most important aspects of palliative care is the comfort of the patients as well as their feelings in the care.
In order to best meet the expectations of cancer patients, some offer early palliative care that is effective in improving both the quality of life of the patient and its life expectancy.
Osteopathy is a manual alternative medicine whose goal is to restore the lack of mobility of tissues. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in the reduction of pain in adult patients in palliative care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Procedures of Locoregional Analgesia and Quality of Life in Palliative Care Units
NCT01094912
Description of the Use of Subcutaneous Acetaminophen in Palliative Care Unit in France: Descriptive Questionnaire Survey
NCT03349853
Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
NCT03936205
Analgesic Self-medication for Acute Pain by Patients Awaiting a Consultation With a General Practitioner
NCT05412407
Tolerance and Efficiency of Paracetamol Subcutaneous Injection
NCT02884609
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Osteopathy
Management will be centered on the skull, the sacrum, the cranio-sacral axis, the entire visceral abdominal and thoracic system.
Questionnaire and treatment
EVA questionnaire every day for 7 days. treatment (real or simulated) at J3 and J5
Simulate
The simulated treatment will be characterized by placing the practitioner's hands on the patient in the areas tested without any intention of treatment.
Questionnaire and treatment
EVA questionnaire every day for 7 days. treatment (real or simulated) at J3 and J5
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire and treatment
EVA questionnaire every day for 7 days. treatment (real or simulated) at J3 and J5
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient hospitalized or admitted to a day hospital that can be followed
* EVA between 40/100 and 60/100
* Signed informed consent
Exclusion Criteria
* Clinical stability of the patient estimated during the duration of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Creteil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHI Creteil
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02655-50
Identifier Type: OTHER
Identifier Source: secondary_id
OSTEOPAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.